The incidence of serious adverse events in a tunisian hospital: a retrospective medical record review study

##plugins.themes.academic_pro.article.main##

Marwène Grira
Thara Larbi
Amira El Ouni
Kamel Bouslama
Meya Abdallah
Ali Harmel
Salwa Hamzaoui
Skander M'rad

Abstract

SUMMARY
Aim : To describe the epidemiology of serious adverse events (SAE) reported in the division of internal medicine at the Mongi Slim university hospital in Tunis, to analyze their causes and contributing factors and compare them to that reported in literature so as to establish prevention strategies when these events were deemed preventable.
Methods This retrospective study collected the medical records of randomly selected 500 index hospitalizations. Records review was conducted in two stages: a primary review that aimed to detect hospitalizations where a SAE was likely to have occurred then a secondary review which purpose was to confirm the presence of the SAE, to determine its nature and its preventability.
Results : SAE were detected in 5.2% of hospitalizations with a preventability of 57.7%. These events were responsible for a prolongation in 27.0% of hospitalizations and disability in 15.4% of cases. They were the cause of admission in 42.9% of hospitalizations in which a SAE occurred. The SAE consisted in adverse drug events in 73.0% of cases, healthcare-associated infections in 19.0% of cases, non-surgical procedures in 4% of cases and pressure ulcers in 4.0% of cases. Age and number of comorbidities were identified as the main risk factors for the occurrence of SAE.
Conclusion : Awareness of the extent and severity of the problem of iatrogenesis is necessary because it is a prerequisite to establishing a culture of patient safety among caregivers.

Keywords:

Serious adverse events; iatrogenesis; patient safety; medical errors; healthcare-associated infections; adverse drug events.

##plugins.themes.academic_pro.article.details##

References

  1. Khon LT CJ, Donaldson MS, eds. To err is human: building a safer health system. U.S. Institute of Medicine. Committee on Quality of Health Care in America.: Washington, D.C. : National Academy Press; 2000.
  2. Report on measuring patient safety: a training workshop. www.emro.who. int/docs/WHO_EM_HCD_066_E_en.pdf. Cairo, Egypt. May 2006.
  3. Wilson RM, Michel P, Olsen S, Gibberd RW, Vincent C, El-Assady R, et al. Patient safety in developing countries: retrospective estimation of scale and nature of harm to patients in hospital. Bmj 2012;344:e832.
  4. Brennan TA, Leape LL, Laird NM, Hebert L, Localio AR, Lawthers AG, et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. The New England journal of medicine 1991;324:370-6.
  5. Wilson RM, Runciman WB, Gibberd RW, Harrison BT, Newby L, Hamilton JD. The Quality in Australian Health Care Study. The Medical journal of Australia 1995;163:458-71.
  6. Thomas EJ, Brennan TA. Incidence and types of preventable adverse events in elderly patients: population based review of medical records.Bmj 2000;320:741-4.
  7. Davis P, Lay-Yee R, Briant R, Ali W, Scott A, Schug S. Adverse events in New Zealand public hospitals II: preventability and clinical context. The New Zealand medical journal 2003;116:U624.
  8. Vincent C, Neale G, Woloshynowych M. Adverse events in British hospitals: preliminary retrospective record review. Bmj 2001;322:517-9.
  9. Baker GR, Norton PG, Flintoft V, Blais R, Brown A, Cox J, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2004;170:1678- 86.
  10. Schioler T, Lipczak H, Pedersen BL, Mogensen TS, Bech KB, Stockmarr A, et al. [Incidence of adverse events in hospitals. A retrospective study of medical records]. Ugeskrift for laeger 2001;163:5370-8.
  11. Zegers M, de Bruijne MC, Wagner C, Groenewegen PP, van der Wal G, de Vet HC. The inter-rater agreement of retrospective assessments of adverse events does not improve with two reviewers per patient record. Journal of clinical epidemiology 2010;63:94-102.
  12. Wilson RM, Harrison BT, Gibberd RW, Hamilton JD. An analysis of the causes of adverse events from the Quality in Australian Health Care Study. The Medical journal of Australia 1999;170:411-5.
  13. Soop M, Fryksmark U, Koster M, Haglund B. The incidence of adverse events in Swedish hospitals: a retrospective medical record review study. International journal for quality in health care : journal of the International Society for Quality in Health Care / ISQua 2009;21:285-91
  14. Runciman WB, Roughead EE, Semple SJ, Adams RJ. Adverse drug events and medication errors in Australia. International journal for quality in health care : journal of the International Society for Quality in Health Care / ISQua 2003;15 Suppl 1:i49-59.
  15. Cresswell KM, Fernando B, McKinstry B, Sheikh A. Adverse drug events in the elderly. British medical bulletin 2007;83:259-74.
  16. Gurwitz JH, Field TS, Harrold LR, Rothschild J, Debellis K, Seger AC, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA : the journal of the American Medical Association 2003;289:1107-16.
  17. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. Bmj 2004;329:15-9.
  18. Enquête nationale de prévalence des infections nosocomiales. http://wwwinvssantefr /publications/2009/enquete_ prevalence_ i n f e c t i o n s _ n o s o c omi a l e s / e n q u e t e _ p r e v a l e n c e _ i n f e c t i o n s _ nosocomiales_ vol1pdf. France 2006.
  19. Sax H, Swiss N. [Nationwide surveillance of nosocomial infections in Switzerland--methods and results of the Swiss Nosocomial Infection Prevalence Studies (SNIP) in 1999 and 2002]. Therapeutische Umschau Revue therapeutique 2004;61:197-203.
  20. Ghannem. Etude descriptive des infections nosocomiales en Tunisie (enquête nationale de prévalence 2005). Faculty of medicine of Sousse; 2009.
  21. Gastmeier P, Kampf G, Wischnewski N, Schumacher M, Daschner F, Ruden H. Importance of the surveillance method: national prevalence studies on nosocomial infections and the limits of comparison. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1998;19:661-7.
  22. Prevalence of nosocomial infections in France: results of the nationwide survey in 1996. The French Prevalence Survey Study Group. The Journal of hospital infection 2000;46:186-93.
  23. Enquête nationale de prévalence des infections nosocomiales. h t t p : / / w w w i n v s s a n t e f r / p u b l i c a t i o n s / 2 0 0 5 / s n m i / p d f /infections_noso_enquetepdf [Internet]. 2001.
  24. Fontaine J, Raynaud-Simon A. [Pressure sores in geriatric medicine: the role of nutrition]. Presse medicale 2008;37:1150-7.
  25. Shaw R, Drever F, Hughes H, Osborn S, Williams S. Adverse events and near miss reporting in the NHS. Quality & safety in health care 2005;14:279-83.
  26. Sutton J, Standen P, Wallace A. Accidents to patients in hospital: a comparative study. Nursing times 1994;90:52-4.
  27. Tan KM, Austin B, Shaughnassy M, Higgins C, McDonald M, Mulkerrin EC, et al. Falls in an acute hospital and their relationship to restraint use. Irish journal of medical science 2005;174:28-31.
  28. Hanger HC, Ball MC, Wood LA. An analysis of falls in the hospital: can we do without bedrails? Journal of the American Geriatrics Society 1999;47:529-31.
  29. Hoonhout LH, de Bruijne MC, Wagner C, Zegers M, Waaijman R, Spreeuwenberg P, et al. Direct medical costs of adverse events in Dutch hospitals. BMC health services research 2009;9:27.